CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
2.015
+0.015 (0.75%)
Apr 24, 2025, 4:00 PM EDT - Market closed
CASI Pharmaceuticals Employees
CASI Pharmaceuticals had 233 employees as of December 31, 2024. The number of employees increased by 57 or 32.39% compared to the previous year.
Employees
233
Change (1Y)
57
Growth (1Y)
32.39%
Revenue / Employee
$122,476
Profits / Employee
-$168,489
Market Cap
31.22M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
CASI News
- 21 days ago - CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company - Accesswire
- 24 days ago - CASI Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Business and Financial Results - Accesswire
- 3 months ago - CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia - Accesswire
- 5 months ago - CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results - Accesswire
- 6 months ago - CASI Pharmaceuticals Receives CTA Approval From China's NMPA for CID-103 in Immune Thrombocytopenia - Accesswire
- 8 months ago - CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE - PRNewsWire
- 8 months ago - CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2024 BUSINESS AND FINANCIAL RESULTS - PRNewsWire
- 9 months ago - CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS - PRNewsWire